The epidemiology of non‐Candida yeast isolated from blood: The Asia Surveillance Study
Open Access
Abstract
Summary: Background: Current guidelines recommend echinocandins as first‐line therapy for candidemia. However, several non‐Candida yeast are non‐susceptible to echinocandins (echinocandin non‐susceptible yeast, ENSY), including Cryptococcus, Geotrichum, Malassezia, Pseudozyma, Rhodotorula, Saprochaete, Sporobolomyces and Trichosporon. In laboratories that are not equipped with rapid diagnostic tools, it often takes several days to identify yeast, and this may lead to inappropriate presumptive use of echinocandins in patients with ENSY fungemia. The aim of this study was to determine the distribution of ENSY species during a 1‐year, laboratory surveillance programme in Asia.Methods: Non‐duplicate yeast isolated from blood or bone marrow cultures at 25 hospitals in China, Hong Kong, India, Singapore, Taiwan and Thailand were analysed. Isolates were considered to be duplicative if they were obtained within 7 days from the same patient.Results: Of 2155 yeast isolates evaluated, 175 (8.1%) were non‐Candida yeast. The majority of non‐Candida yeast were ENSY (146/175, 83.4%). These included Cryptococcus (109 isolates), Trichosporon (23), Rhodotorula (10) and Malassezia (4). The proportion of ENSY isolates (146/2155, 6.7%) differed between tropical (India, Thailand and Singapore; 51/593, 8.6%) and non‐tropical countries/regions (China, Hong Kong and Taiwan; 95/1562, 6.1%, P = 0.038). ENSY was common in outpatient clinics (25.0%) and emergency departments (17.8%) but rare in intensive care units (4.7%) and in haematology‐oncology units (2.9%). Cryptococcus accounted for the majority of the non‐Candida species in emergency departments (21/24, 87.5%) and outpatient clinics (4/5, 80.0%).Conclusions: Isolation of non‐Candida yeast from blood cultures was not rare, and the frequency varied among medical units and countries.Keywords
Funding Information
- Pfizer (201108019RC)
- Ministry of Science and Technology, Taiwan (NSC 102-2314-B-002 -158 -MY3)
This publication has 40 references indexed in Scilit:
- Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010Journal of Microbiology, Immunology and Infection, 2014
- Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human PathogensPLOS ONE, 2012
- Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective surveyJournal of Antimicrobial Chemotherapy, 2012
- Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancerJournal of Infection, 2012
- Epidemiology and Antifungal Susceptibility of Bloodstream Fungal Isolates in Pediatric Patients: a Spanish Multicenter Prospective SurveyJournal of Clinical Microbiology, 2011
- Current Knowledge of Trichosporon spp. and TrichosporonosisClinical Microbiology Reviews, 2011
- Emerging opportunistic yeast infectionsThe Lancet Infectious Diseases, 2011
- National Surveillance of Fungemia in Denmark (2004 to 2009)Journal of Clinical Microbiology, 2011
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion TestingJournal of Clinical Microbiology, 2009
- A first Portuguese epidemiological survey of fungaemia in a university hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008